It is a pharma private limited company based in Aurangabad, Maharashtra, India, established in 2020.
2020 | Aurangabad, Maharashtra, India | ActiveShakambhari Pharmaceuticals Private Limited, a active private limited company, was established on 24 May 2020 in Aurangabad, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24230MH2020PTC339967. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Formerly known as Zyrus Pharmaceutical Private Limited. Its leadership includes Swapna Ganeshrao Joshi (Director), Rajkumar Kishanrao Kulkarni (Director). Past directors included Rajkumar Kishanrao Kulkarni, Sandeep Madhukarrao Kulkarni, Nitin Subhashrao Patil. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 03-A,, Mukund Co.-Op. Housing Society, Aurangabad, Maharashtra, 431001.
U24230MH2020PTC339967
339967
24 May 2020
₹1.00 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Shakambhari Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swapna Ganeshrao Joshi | Director | 21 Feb 2022 | Current |
| Rajkumar Kishanrao Kulkarni | Director | 13 Jul 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 21 Feb 2022 | Past |
| Pramod Abcsdd | Director | 01 Jul 2021 | Past |
| Pramod Abcsdd | Director | 13 Jul 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Shakambhari Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 49.71% decrease in profit. The company's net worth observed a substantial decline by a decrease of 34.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Shakambhari Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Shakambhari Pharmaceuticals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Shakambhari Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shakambhari Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Shakambhari Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
The activity Shakambhari Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
The activity Rajkumar Kishanrao Kulkarni was appointed as a Director was appointed as a Director on 13 Jul 2023 & has been associated with this company since 2 years 5 months . was completed.
Progress on Swapna Ganeshrao Joshi was appointed as a Director was appointed as a Director on 21 Feb 2022 & has been associated with this company since 3 years 9 months . was documented.
Progress on Shakambhari Pharmaceuticals Private Limited was registered on 24 May 2020 with Roc Mumbai & aged 5 years 6 months as per MCA records. was documented.
The CIN of Shakambhari Pharmaceuticals Private Limited is U24230MH2020PTC339967.
Shakambhari Pharmaceuticals Private Limited is headquartered at Plot No. 03-A,, Mukund Co.-Op. Housing Society, Aurangabad, Maharashtra, 431001.
Shakambhari Pharmaceuticals Private Limited was incorporated on 24 May 2020.
The current directors of Shakambhari Pharmaceuticals Private Limited are
The primary industry of Shakambhari Pharmaceuticals Private Limited is Pharma.
Shakambhari Pharmaceuticals Private Limited is unlisted.
The authorized capital of Shakambhari Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX